Cancer Imaging

Papers
(The TQCC of Cancer Imaging is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins39
Predicting microvascular invasion in hepatocellular carcinoma: a deep learning model validated across hospitals38
A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy38
Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer32
Robustness of magnetic resonance radiomic features to pixel size resampling and interpolation in patients with cervical cancer31
The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI31
Tumor stiffness measured by shear wave elastography correlates with tumor hypoxia as well as histologic biomarkers in breast cancer30
CT-based radiomics features in the prediction of thyroid cartilage invasion from laryngeal and hypopharyngeal squamous cell carcinoma28
A CT-based radiomics nomogram for distinguishing between benign and malignant bone tumours28
Long-axial field-of-view PET/CT: perspectives and review of a revolutionary development in nuclear medicine based on clinical experience in over 7000 patients27
Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact26
Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study25
High resolution MRI-based radiomic nomogram in predicting perineural invasion in rectal cancer25
Value of 18F-FDG-PET to predict PD-L1 expression and outcomes of PD-1 inhibition therapy in human cancers24
Validation of 18F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study24
Dynamic contrast-enhanced MRI radiomics nomogram for predicting axillary lymph node metastasis in breast cancer23
Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer23
Diagnostic efficiency of whole-body 18F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer23
Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study22
Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy21
Magnetic resonance imaging-based radiomics signature for preoperative prediction of Ki67 expression in bladder cancer20
Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as g19
Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma18
Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach18
Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma16
Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study16
CT-based multi-phase Radiomic models for differentiating clear cell renal cell carcinoma16
MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy15
Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics15
Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography 15
FLAIR hyperintensity along the brainstem surface in leptomeningeal metastases: a case series and literature review15
Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade14
Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy14
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib14
Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC14
CT texture analysis and node-RADS CT score of mediastinal lymph nodes - diagnostic performance in lung cancer patients14
Baseline MRI-based radiomics model assisted predicting disease progression in nasopharyngeal carcinoma patients with complete response after treatment14
Feasibility and possible value of quantitative semi-automated diffusion weighted imaging volumetry of neuroblastic tumors13
Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives13
Nomograms based on SUVmax of 18F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma13
PET/CT variants and pitfalls in malignant melanoma13
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET13
Automatic segmentation of head and neck primary tumors on MRI using a multi-view CNN12
Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma12
Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CT12
“Real-world” radiomics from multi-vendor MRI: an original retrospective study on the prediction of nodal status and disease survival in breast cancer, as an exemplar to promote discussion of the wider12
Detection of prostate cancer using diffusion-relaxation correlation spectrum imaging with support vector machine model – a feasibility study11
Differentiating prostate cancer from benign prostatic hyperplasia using whole-lesion histogram and texture analysis of diffusion- and T2-weighted imaging11
PET/MR fusion texture analysis for the clinical outcome prediction in soft-tissue sarcoma11
The prognostic value of 18F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients11
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma11
Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review11
Comparison of the pre-treatment functional MRI metrics’ efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy11
The current status and future prospects for molecular imaging-guided precision surgery11
Magnetic resonance diffusion kurtosis imaging in differential diagnosis of benign and malignant renal tumors11
The comparative study of color doppler flow imaging, superb microvascular imaging, contrast-enhanced ultrasound micro flow imaging in blood flow analysis of solid renal mass10
Exploration of spatial distribution of brain metastasis from small cell lung cancer and identification of metastatic risk level of brain regions: a multicenter, retrospective study10
Application of diffusion kurtosis tensor MR imaging in characterization of renal cell carcinomas with different pathological types and grades10
Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer10
Tumor stiffness measured by 3D magnetic resonance elastography can help predict the aggressiveness of endometrial carcinoma: preliminary findings10
The value of contrast‐enhanced ultrasound in determining the location of sentinel lymph nodes in breast cancer10
Post-PRRT scans: which scans to make and what to look for10
Value of conventional magnetic resonance imaging texture analysis in the differential diagnosis of benign and borderline/malignant phyllodes tumors of the breast10
Utility of the deep learning technique for the diagnosis of orbital invasion on CT in patients with a nasal or sinonasal tumor10
Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma9
Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy9
Magnetic resonance imaging of pure ovarian dysgerminoma: a series of eight cases9
Are radiomics features universally applicable to different organs?9
Imaging of head and neck mucosa-associated lymphoid tissue lymphoma (MALToma)9
Associations between dynamic-contrast enhanced MRI and tumor infiltrating lymphocytes and tumor-stroma ratio in head and neck squamous cell cancer9
Determining the elastography strain ratio cut off value for differentiating benign from malignant breast lesions: systematic review and meta-analysis9
Clustering subtypes of breast cancer by combining immunohistochemistry profiles and metabolism characteristics measured using FDG PET/CT9
Native T1 mapping for differentiating the histopathologic type, grade, and stage of rectal adenocarcinoma: a pilot study9
Development and validation of a CT-texture analysis nomogram for preoperatively differentiating thymic epithelial tumor histologic subtypes9
Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments9
Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors8
Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma8
Integrated slice-specific dynamic shimming diffusion weighted imaging (DWI) for rectal Cancer detection and characterization8
Prognostic value of cervical nodal necrosis on staging imaging of nasopharyngeal carcinoma in era of intensity-modulated radiotherapy: a systematic review and meta-analysis8
Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features8
Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI8
Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study8
MR imaging features of pancreatic schwannoma: a Chinese case series and a systematic review of 25 cases8
Whole-body diffusion-weighted MRI of normal lymph nodes: prospective apparent diffusion coefficient histogram and nodal distribution analysis in a healthy cohort8
Multiparametric detection and outcome prediction of pancreatic cancer involving dual-energy CT, diffusion-weighted MRI, and radiomics8
The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy8
Contrast enhanced mammography: focus on frequently encountered benign and malignant diagnoses8
What is the impact of dynamic contrast-enhancement sequence in the Vesical Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis8
Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACE8
Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance8
Texture analysis of iodine maps and conventional images for k-nearest neighbor classification of benign and metastatic lung nodules8
Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma8
Quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging to predict lymphovascular invasion and survival outcome in breast cancer7
Predictive CT features for the diagnosis of primary pulmonary mucoepidermoid carcinoma: comparison with squamous cell carcinomas and adenocarcinomas7
Normal size of benign upper neck nodes on MRI: parotid, submandibular, occipital, facial, retroauricular and level IIb nodal groups7
Radiology reporting in oncology—oncologists’ perspective7
Predicting prognosis of nasopharyngeal carcinoma based on deep learning: peritumoral region should be valued7
Differentiation of renal angiomyolipoma without visible fat from small clear cell renal cell carcinoma by using specific region of interest on contrast-enhanced CT: a new combination of quantitative t7
Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors7
Application of SPECT and PET / CT with computer-aided diagnosis in bone metastasis of prostate cancer: a review7
Multi-tracer and multiparametric PET imaging to detect the IDH mutation in glioma: a preclinical translational in vitro, in vivo, and ex vivo study7
TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience7
Three-dimensional analysis of human pancreatic cancer specimens by phase-contrast based X-ray tomography – the next dimension of diagnosis7
Can preoperative liver MRI with gadoxetic acid help reduce open-close laparotomies for curative intent pancreatic cancer surgery?7
A radiomics-based deep learning approach to predict progression free-survival after tyrosine kinase inhibitor therapy in non-small cell lung cancer7
Iodine-related attenuation in contrast-enhanced dual-energy computed tomography in small-sized solid-type lung cancers is associated with the postoperative prognosis6
CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors6
Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumab6
Ultrasound features of medullary thyroid cancer as predictors of biological behavior6
Validation of the ALBI-TAE model and comparison of seven scoring systems for predicting survival outcome in patients with intermediate‐stage hepatocellular carcinoma undergoing chemoembolization6
A comparative study of methods for determining Intravoxel incoherent motion parameters in cervix cancer6
Novel applications of molecular imaging to guide breast cancer therapy6
Sarcomatoid renal cell carcinoma: MRI features and their association with survival6
Imaging glymphatic response to glioblastoma6
Primary disease sites and patterns of spread in cases of neurolymphomatosis in the orbit associated with lymphoma6
Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma6
The diagnostic value of contrast-enhanced ultrasonography in breast ductal abnormalities6
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer6
MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison6
The value of bone marrow, liver, and spleen imaging in diagnosis, prognostication, and follow-up monitoring of myeloproliferative neoplasms: a systematic review6
Endometrial carcinoma: use of tracer kinetic modeling of dynamic contrast-enhanced MRI for preoperative risk assessment6
Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinoma6
0.070869922637939